MediPoint: Sports Medicine - Global Analysis and Market Forecasts

LONDON, Aug. 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

MediPoint: Sports Medicine - Global Analysis and Market Forecasts

http://www.reportbuyer.com/pharma_healthcare/healthcare/medipoint_sports_medicine_global_analysis_market_forecasts.html

MediPoint: Sports Medicine - Global Analysis and Market Forecasts

Summary

This report focuses on the sports medicine market, which includes implants and arthroscopic capital equipment. The orthopedic sports medicine market has been estimated in this report and covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compound annual growth rates (CAGR). GlobalData's analysis shows that while the orthopedics implant market is mature, sports medicine is an area with the potential for significant international growth. With the market, the US remains to be the largest market with the EU to follow and growing. The APAC region while markedly smaller has a large potential patient population.The top six to seven market leaders continue to dominate the market through technological innovation and investment in establishing strong distribution networks. The major opportunity lies within technological advancement and the clinical trials to prove effectiveness of new techniques.

Highlights

Key Questions Answered

- The sports medicine market is expected to continue its growth through the forecast period with growth driven by young athletes injuring themselves more and a growing elderly population that wishes to continue their recreational activity. (Q). What are the primary patient segments, indications and different product offerings in sports medicine?
- Orthopedics has seen rapid development in materials research and new techniques for surgical treatment. And sports medicine is one of the higher growth markets. (Q). What specific technologies will drive the market? (Q). How have the indications changed and are procedural numbers growing proportionately to market size?(Q). What are the future trends and drivers for growth in this market?
- Joint replacement in orthopedics is growing rapidly in the extremities and less so in large joints.(Q). Is arthroscopic surgery a viable alternative?(Q). Do we see pricing pressure in the sports medicine implants?(Q). Which product segment will have the most innovation?
- The top players in this market are dominating sports medicine implants and equipment worldwide. (Q). What role do smaller players have in grabbing market share in the different global regions? (Q). Who are the large players in sports medicine in each product segment?

Reasons to buy

- "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading Orthopedic Sports MedicineSurgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
1 Table of Contents
2 Introduction 23
2.1 Catalyst 24
2.2 Related Reports 26
2.3 Upcoming Related Reports 26
3 Clinical Outcomes 27
3.1 Conservative Treatments 27
3.1.1 Immobilization and Bracing 28
3.1.2 Physical Therapy 28
3.1.3 Muscle Stimulation 29
3.2 Drug Therapy 29
3.2.1 Nutritional Supplements 30
3.2.2 Analgesics and NSAIDs 30
3.2.3 Corticosteroids 30
3.2.4 Viscosupplementation 30
3.3 Soft Tissue Repair 31
3.4 Arthroscopy 33
3.5 Plates and Screws 34
3.6 Joint Replacement 35
4 Industry Overview 36
4.1 Overview 36
4.2 Procedure Trends 37
4.2.1 US 37
4.2.2 EU 39
4.2.3 Asia-Pacific Region 41
4.2.4 South America 42
4.3 Market Access 43
4.3.1 US 43
4.3.2 EU 48
4.3.3 Asia-Pacific Region 56
4.3.4 South America 63
4.4 Disputes and Settlements 66
4.4.1 Smith & Nephew Granted an Injunction Against Arthrex 66
4.4.2 KFx Medical and Smith & Nephew Enter Into Licensing Agreement 66
4.4.3 KFx Medical Wins Patent Infringement Lawsuit Against Arthrex 67
4.4.4 ArthroCare and Smith & Nephew Settle Legal Disputes 67
4.5 Mergers, Acquisitions, Partnerships, and Other Deals 67
4.5.1 Stryker Acquires Pivot Medical 67
4.5.2 Smith & Nephew Announces Acquisition of ArthroCare 67
4.5.3 Smith & Nephew Acquires Plato Grup Assets 68
4.5.4 Smith & Nephew Announces Acquisition of Its Brazil Distribution Business 68
4.5.5 Kensey Nash Acquires Minority Stake in Orteq Sports Medicine 68
4.5.6 Tornier Acquires C2M Medical 68
4.5.7 Tornier Signs Licensing Agreement with T.A.G. Medical Products Corporation 68
4.5.8 Biomet Acquires Cartilix 69
4.5.9 Biomet Sports Medicine Enters Into Deal With Marc Tec 69
4.6 Economic Impact 69
4.6.1 Developed Countries 69
4.6.2 Emerging Markets 71
5 Unmet Needs 73
5.1 Long-Term Clinical Data 73
5.1.1 Hip Arthroscopic Implants Clinical Data 73
5.1.2 Rotator Cuff Injury Clinical Data 73
5.2 Cartilage and Meniscal Repair Product Development 74
5.2.1 Knee Meniscus Treatment 74
5.2.2 Hip Cartilage Product Development 76
5.3 Biologics for Faster Healing 77
5.4 Standardization and Improvement of Instruments 78
5.4.1 Hip and Shoulder Instrumentation 78
5.4.2 Screwdriver Standardization 78
5.5 Fellowship Training Programs 79
5.6 Advanced Materials Research 80
5.7 Bioabsorbable Technology Development 81
5.8 Centralization 83
5.9 Need for Cost-Containment 83
5.10 Suture Anchor Product Development 84
6 Market Opportunity Analysis 86
6.1 Adding More Training Programs 86
6.2 Product Line Extensions 86
6.3 Lack of Pricing Pressure in Sports Medicine 87
6.4 Mergers and Acquisitions 88
6.5 Seasonality of Sports Medicine 89
6.6 Emerging Markets 89
6.7 Minimally-Invasive Surgical Preference 90
7 Market Drivers, Barriers and Substitutes 91
7.1 Driver: Rising Prevalence 91
7.1.1 Sports-Related Injuries 91
7.1.2 Aging 91
7.1.3 Trauma 92
7.2 Driver: Hip Arthroscopy 93
7.2.1 Femoroacetabular Impingement Growth 94
7.2.2 Hip Arthroscopy Fellowship Training Programs 95
7.3 Driver: Knee and Shoulder Arthroscopy 95
7.4 Driver: Revision Surgery 96
7.5 Driver: Patient Demand and Awareness 97
7.6 Driver: Orthobiologics Development 98
7.6.1 Bone Grafts 98
7.6.2 Platelet-Rich Plasma 99
7.7 Driver: Rising Competition and Innovation Through Small Players 99
7.8 Driver: Materials Development 99
7.8.1 Composite Materials and Biopolymers 100
7.8.2 Bioabsorbables 100
7.8.3 Metallic Alloys in Orthopedics 101
7.9 Barrier: Arthroscopy's Questionable Outcomes 102
7.9.1 Hip Arthroscopy 102
7.9.2 Knee Arthroscopy 103
7.10 Barrier: Steep Learning Curve 104
7.11 Barrier: Reimbursement 104
7.12 Barrier: Burden of Rising Regulation 106
7.13 Barrier: Proving Efficacy 107
7.14 Barrier: Medical Device Excise Tax 108
7.15 Substitute: Open Surgery Versus Minimally-Invasive Arthroscopy 108
7.16 Substitute: Conservative Treatment Options 109
8 Competitive Assessment 110
8.1 Overview 110
8.2 Marketed Products in Sports Medicine 110
8.2.1 Arthrex 110
8.2.2 ArthroCare Corporation 117
8.2.3 Biomet 121
8.2.4 ConMed Corporation 125
8.2.5 DePuy Mitek 130
8.2.6 Smith & Nephew 134
8.2.7 Stryker 136
8.2.8 Tornier 139
9 Pipeline Assessment 140
9.1 Overview 140
9.2 Product Profiles 140
9.2.1 Bioretec Drug-Releasing Screws 140
9.2.2 Nanova Bioabsorbable Bone Screws 140
9.2.3 MinInvasive Arthroscopic Suture Passer 140
9.2.4 SpineSmith Pipeline 141
9.2.5 DePuy Mitek FMS VUE 141
9.2.6 Pivot Medical Hip Arthroscopy System 141
9.2.7 University of Florida Shoulder Labral Anchor Delivery System 141
9.2.8 University of California at San Diego Cartilage Regeneration Device 141
10 Clinical Trials to Watch 142
10.1 Overview 142
10.2 Can Shoulder Arthroscopy Work (CSAW) Study 142
10.3 Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear 142
10.4 Knee Arthroscopy Cohort Southern Denmark 143
10.5 Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement 143
10.6 Femoroacetabular Impingement Randomized Controlled Trial 144
10.7 Multicenter ACL Revision Study (MARS) 144
10.8 Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability 145
10.9 Microfracture in the Knee Study 145
10.10 Single- Versus Double-Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears 146
10.11 Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE) 146
10.12 Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty 147
10.13 Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma 148
10.14 Tibial Tunnel Widening in ACL Reconstruction-Comparing Two Bioscrews 148
11 Current and Future Players 149
11.1 Trends in Corporate Strategy 149
11.2 Company Profiles 150
11.2.1 Arthrex 150
11.2.2 ArthroCare Corporation 152
11.2.3 Biomet 154
11.2.4 ConMed Corporation 157
11.2.5 DePuy Companies 159
11.2.6 Smith & Nephew 161
11.2.7 Stryker 163
11.2.8 Tornier 165
11.2.9 Wright Medical Group 168
11.2.10 Other Key Players in Sports Medicine 171
12 Market Outlook 177
12.1 Company Market Share 177
12.1.1 Overview 177
12.1.2 US 177
12.1.3 EU Market Share 178
12.1.4 Asia-Pacific Market Share 181
12.1.5 South America Market Share 183
12.2 By Market Segment 184
12.2.1 Overview 184
12.2.2 Arthroscopy Implants 185
12.2.3 Arthroscopic Shavers 186
12.2.4 Arthroscopes 187
12.2.5 Arthroscopic Radio Frequency Wands 188
12.2.6 Arthroscopic Visualization Systems 189
12.2.7 Arthroscopic Fluid Management Systems 190
12.3 By Geography 192
12.3.1 Global Overview 192
12.3.2 US 195
12.3.3 EU 198
12.3.4 Asia-Pacific 209
12.3.5 South America 215
13 Appendix 218
13.1 Bibliography 218
13.2 Abbreviations 228
13.3 Research Methodology 233
13.3.1 Overview 233
13.3.2 Coverage 233
13.3.3 Secondary Research 233
13.4 Physicians and Specialists Included in this Study 235
13.4.1 Dr. Henry D.E. Atkinson 235
13.4.2 Dr. Joshua Alpert 235
13.4.3 Dr. Andrea Ferretti 235
13.4.4 Dr. Alejandro Gonzalez Della Valle 235
13.4.5 Dr. Andreas Imhoff 235
13.4.6 Dr. Marcello Zaia Oliveira 235
13.4.7 Dr. Vidhya Ravi 236
13.4.8 Dr. Elvire Servien 236
13.4.9 Dr. Yotaro Yamakado 236
13.5 Primary Research 237
13.5.1 Primary Research - Key Opinion Leader Interviews 237
13.5.2 Primary Research - Physician and Industry Interviews 237
13.5.3 Expert Panel Validation 238
13.6 Forecasting Methodology 238
13.7 About the Authors 240
13.7.1 Analysts 240
13.7.2 Global Head of Healthcare 241
13.8 About MediPoint 242
13.9 About GlobalData 242
13.10 Disclaimer 242

1.1 List of Tables

Table 1: Most Common Soft Tissue Injuries to the Extremities in Sports Medicine 32
Table 2: Growth Rates for Arthroscopy by Joint in the US, 2013-2020 38
Table 3: EU Growth Rate for Arthroscopy by Joint and Country, 2013-2020 40
Table 4: APAC Growth Rate for Arthroscopy by Joint and Country, 2013-2020 42
Table 5: Brazil Growth Rate for Arthroscopy by Joint, 2013-2020 43
Table 6: Medicare ICD-9 Diagnosis Codes for Common Sports Medicine Injuries, 2013 46
Table 7: Medicare National Adjusted Reimbursement Rates for Common Sports Medicine Injuries for Hospital Outpatient Treatment, 2013 47
Table 8: Medicare DRG Payments to Hospitals for Common Sports Medicine Injuries, 2013 48
Table 9: Primary Differences Between FDA Approval and CE-Marking of Medical Devices 49
Table 10: Direct, Indirect, and Intangible Costs of Orthopedics 71
Table 11: Potential Market for Meniscus Treatment Types 75
Table 12: Metal Implant CharacteristicsThat Can Be Improved 101
Table 13: Arthrex Shoulder Implants 112
Table 14: Arthrex, Shoulder Instrumentation 113
Table 15: Arthrex, Knee Sutures and Suture Anchors 113
Table 16: Arthrex, Knee Graft Fixation Devices and Meniscal Products 114
Table 17: Arthrex, Hip Implants and Instruments 115
Table 18: Arthrex, Arthroscopy Procedure Capital Equipment 116
Table 19: Arthrex, Implants SWOT Analysis 116
Table 20: Arthrex, Instrumentation SWOT Analysis 117
Table 21: Arthrocare, Suture Implants 118
Table 22: ArthroCare, Suture Management Products 119
Table 23: ArthroCare, Cruciate Ligament Graft Fixation Products 120
Table 24: ArthroCare, Capital Equipment and Instruments 120
Table 25: ArthroCare, Implants SWOT Analysis 121
Table 26: Arthrocare, Instruments and Capital Equipment SWOT Analysis 121
Table 27: Biomet, Shoulder Arthroscopy Products 122
Table 28: Biomet, Knee Arthroscopy Products 123
Table 29: Biomet's Other Joints Arthroscopy Products 124
Table 30: Biomet, Capital Equipment Sports Medicine Products 124
Table 31: Biomet Implants SWOT Analysis 125
Table 32: Biomet, Capital Equipment SWOT Analysis 125
Table 33: ConMed, Shoulder Arthroscopy Products 126
Table 34: ConMed, Knee Arthroscopy Products 127
Table 35: ConMed, Small Joint and Hip Arthroscopy Products 128
Table 36: ConMed, Instruments and Capital Equipment 129
Table 37: ConMed, Implants SWOT Analysis 129
Table 38: ConMed, Capital Equipment SWOT Analysis 130
Table 39: DePuy Mitek, Fixation Devices 131
Table 40: DePuy, Mitek Instruments 132
Table 41: DePuy Mitek, Capital Equipment 133
Table 42: DePuy Mitek Implants, SWOT Analysis 133
Table 43: DePuy Mitek, Capital Equipment SWOT Analysis 133
Table 44: Smith & Nephew, Fixation Devices 134
Table 45: Smith & Nephew, Instruments and Capital Equipment 135
Table 46: Smith & Nephew Implants, SWOT Analysis 136
Table 47: Smith & Nephew, Capital Equipment SWOT Analysis 136
Table 48: Stryker, Fixation Devices 137
Table 49: Stryker, Instrumentation 137
Table 50: Stryker, Capital Equipment 138
Table 51: Stryker, Fixation Devices SWOT Analysis 138
Table 52: Stryker, Instrumentation and Capital Equipment SWOT Analysis 138
Table 53: Tornier Sports Medicine Products 139
Table 54: Tornier, Product Family SWOT Analysis 139
Table 55: Can Shoulder Arthroscopy Work (CSAW) 142
Table 56: Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear 143
Table 57: Knee Arthroscopy Cohort Southern Denmark 143
Table 58: Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement 144
Table 59: Femoroacetabular Impingement Randomized Controlled Trial 144
Table 60: Multicenter ACL Revision Study (MARS) 145
Table 61: Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability 145
Table 62: Results at 10 to 14 Years After Microfracture in the Knee 146
Table 63: Single Versus Double Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears 146
Table 64: Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE) 147
Table 65: Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty 147
Table 66: Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma in Large to Massive Tears 148
Table 67: Tibial Tunnel Widening in Anterior Cruciate Ligament Reconstruction Comparing Two Bioscrews 148
Table 68: Company Profile - Arthrex 151
Table 69: SWOT Analysis - Arthrex 152
Table 70: Company Profile - ArthroCare Corporation 153
Table 71: SWOT Analysis - ArthroCare Corporation 154
Table 72: Company Profile - Biomet 155
Table 73: SWOT Analysis - Biomet 156
Table 74: Company Profile - ConMed Corporation 158
Table 75: SWOT Analysis - ConMed Corporation 159
Table 76: Company Profile - DePuy Companies 160
Table 77: SWOT Analysis - DePuy Companies 161
Table 78: Company Profile - Smith & Nephew 162
Table 79: SWOT Analysis - Smith & Nephew 163
Table 80: Company Profile - Stryker 164
Table 81: SWOT Analysis - Stryker 165
Table 82: Company Profile - Tornier 166
Table 83: SWOT Analysis - Tornier 167
Table 84: Company Profile - Wright Medical Group 169
Table 85: SWOT Analysis - Wright Medical Group 170
Table 86: Other Sports Medicine Companies in the US Market 171
Table 87: Other Sports Medicine Companies in the EU Market 172
Table 88: Other Sports Medicine Companies in the APAC Market 174
Table 89: Global Sports Medicine Sales Forecast ($m), 2011-2020 184
Table 90: Global Sports Medicine Sales Forecast ($m), Arthroscopy Implants, 2011-2020 185
Table 91: Global Sports Medicine Sales Forecast ($m), Arthroscopic Shavers, 2011-2020 186
Table 92: Global Sports Medicine Sales Forecast ($m), Arthroscopes, 2011-2020 187
Table 93: Global Sports Medicine Sales Forecast ($m), Arthroscopic RF Wands, 2011-2020 189
Table 94: Global Sports Medicine Sales Forecast ($m), Arthroscopic Visualization Systems, 2011-2020 190
Table 95: Global Sports Medicine Sales Forecast ($m), Arthroscopic Fluid Management Systems, 2011-2020 191
Table 96: Global Sports Medicine Implant and Capital Equipment Sales ($m) Forecast by Country, 2011-2020 193
Table 97: US Sports Medicine Sales Forecast ($m), 2011-2020 197
Table 98: EU Sports Medicine Sales Forecast ($m), 2011-2020 199
Table 99: France Sports Medicine Sales Forecast ($m), 2011-2020 201
Table 100: Germany Sports Medicine Sales Forecast ($m), 2011-2020 203
Table 101: Italy Sports Medicine Sales Forecast ($m), 2011-2020 205
Table 102: Spain Sports Medicine Sales Forecast ($m), 2011-2020 207
Table 103: UK Sports Medicine Sales Forecast ($m), 2011-2020 208
Table 104: Japan Sports Medicine Sales Forecast ($m), 2011-2020 210
Table 105: China Sports Medicine Sales Forecast ($m), 2011-2020 212
Table 106: India Sports Medicine Sales Forecast ($m), 2011-2020 214
Table 107: Brazil Sports Medicine Sales Forecast ($m), 2011-2020 217
Table 108: Primary Research Interviews Completed in Sports Medicine 238

1.2 List of Figures
Figure 1: Global Arthroscopic Procedure Volumes by Joint, 2011-2020 36
Figure 2: US Arthroscopic Procedure Volumes, 2011-2020 37
Figure 3: US Arthroscopic Procedure Volumes by Joint, 2011-2020 38
Figure 4: EU Arthroscopic Procedure Volumes, 2011-2020 39
Figure 5: EU Arthroscopic Procedure Volumes by Joint, 2011-2020 40
Figure 6: APAC Region Arthroscopic Procedure Volumes, 2011-2020 41
Figure 7: Brazil Arthroscopic Procedure Volumes, 2011-2020 42
Figure 8: Sources of Orthopedic Trauma (%) (n=103) 93
Figure 9: US Market Share for Arthroscopy, 2012 178
Figure 10: France Market Share for Arthroscopy, 2012 179
Figure 11: Germany Market Share for Arthroscopy, 2012 179
Figure 12: Italy Market Share for Arthroscopy, 2012 180
Figure 13: Spain Market Share for Arthroscopy, 2012 180
Figure 14: UK Market Share for Arthroscopy, 2012 181
Figure 15: Japan Market Share for Arthroscopy, 2012 182
Figure 16: China Market Share for Arthroscopy, 2012 182
Figure 17: India Market Share for Arthroscopy, 2012 183
Figure 18: Brazil Market Share for Arthroscopy, 2012 183
Figure 19: Global Sports Medicine Sales Forecast ($m), 2011-2020 185
Figure 20: Global Sports Medicine Sales Forecast ($m), Arthroscopy Implants, 2011-2020 186
Figure 21: Global Sports Medicine Sales Forecast ($m), Arthroscopic Shavers, 2011-2020 187
Figure 22: Global Sports Medicine Sales Forecast ($m), Arthroscopes, 2011-2020 188
Figure 23: Global Sports Medicine Sales Forecast ($m), Arthroscopic RF Wands, 2011-2020 189
Figure 24: Global Sports Medicine Sales Forecast ($m), Arthroscopic Visualization Systems, 2011-2020 190
Figure 25: Global Sports Medicine Sales Forecast ($m), Arthroscopic Fluid Management Systems, 2011-2020 191
Figure 26: Arthroscopy Implants Revenue by Major Market, 2013 and 2020 194
Figure 27: Arthroscopy Capital Equipment Revenue by Major Market, 2013 and 2020 195
Figure 28: US Sports Medicine Sales Forecast ($m), 2011-2020 197
Figure 29: EU Sports Medicine Sales Forecast ($m), 2011-2020 199
Figure 30: France Sports Medicine Sales Forecast ($m), 2011-2020 201
Figure 31: Germany Sports Medicine Sales Forecast ($m), 2011-2020 204
Figure 32: Italy Sports Medicine Sales Forecast ($m), 2011-2020 206
Figure 33: Spain Sports Medicine Sales Forecast ($m), 2011-2020 207
Figure 34: UK Sports Medicine Sales Forecast ($m), 2011-2020 209
Figure 35: Japan Sports Medicine Sales Forecast ($m), 2011-2020 211
Figure 36: China Sports Medicine Sales Forecast ($m), 2011-2020 213
Figure 37: India Sports Medicine Sales Forecast ($m), 2011-2020 215
Figure 38: Brazil Sports Medicine Sales Forecast ($m), 2011-2020 217


Read the full report:
MediPoint: Sports Medicine - Global Analysis and Market Forecasts

http://www.reportbuyer.com/pharma_healthcare/healthcare/medipoint_sports_medicine_global_analysis_market_forecasts.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer